QIPT
Quipt Home Medical Corp. (QIPT
NASDAQ · Healthcare · Medical - Devices · US
$3.65
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+3.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Dec 15, 2025 | Crawford Gregory John · director, officer: President/CEO | M-Exempt | 581,000 | $1.11 |
| Dec 15, 2025 | Crawford Gregory John · director, officer: President/CEO | M-Exempt | 2,500 | $1.11 |
| Mar 25, 2025 | Wessel Brian Joseph · director | A-Award | 183,135 | $0.00 |
| Mar 25, 2025 | Roehrig Thomas · officer: Chief Accounting Officer | A-Award | 110,000 | $0.00 |
| Mar 25, 2025 | Miles Mark Alan · officer: Chief Compliance Officer | A-Award | 110,000 | $0.00 |
| Mar 25, 2025 | Mehta Hardik · officer: Chief Financial Officer | A-Award | 343,347 | $0.00 |
| Mar 25, 2025 | Greenberg Mark Alan · director | A-Award | 211,504 | $0.00 |
| Mar 25, 2025 | Gamble Patrick Dennis · officer: Exec. VP Operations | A-Award | 20,000 | $0.00 |
| Mar 25, 2025 | Crawford Gregory John · director, officer: President/CEO | A-Award | 936,000 | $0.00 |
| Mar 25, 2025 | Carter Kevin A. · director | A-Award | 174,767 | $0.00 |
| Mar 25, 2025 | Bachelder David · officer: Exec. VP Operations | A-Award | 20,000 | $0.00 |
| Mar 18, 2025 | Mehta Hardik · officer: Chief Financial Officer | M-Exempt | 115,624 | $0.00 |
| Mar 18, 2025 | Wessel Brian Joseph · director | M-Exempt | 70,625 | $0.00 |
| Mar 18, 2025 | Greenberg Mark Alan · director | M-Exempt | 115,625 | $0.00 |
| Mar 18, 2025 | Crawford Gregory John · director, officer: President/CEO | M-Exempt | 118,750 | $0.00 |
| Mar 18, 2025 | Carter Kevin A. · director | M-Exempt | 53,124 | $0.00 |
| Mar 18, 2025 | Roehrig Thomas · officer: Chief Accounting Officer | M-Exempt | 39,375 | $0.00 |
| Dec 30, 2024 | Gamble Patrick Dennis · officer: Exec VP Operations | Purchase | 10,000 | $2.47 |
| Dec 30, 2024 | Gamble Patrick Dennis · officer: Exec VP Operations | Purchase | 7,000 | $2.42 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 1Reduced 0Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | Increased | 481,791 | Mar 25, 2026 |
| GOLDMAN SACHS GROUP INC | Sold Out | 0 | Mar 25, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 27, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Dec 15, 2025